A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999.
about
Association between changes in air pollution levels during the Beijing Olympics and biomarkers of inflammation and thrombosis in healthy young adults.Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study.Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studiesAssociation of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression.Evidence-based percutaneous closure of the left atrial appendage in patients with atrial fibrillationEffects of depressive and anxious symptoms on norepinephrine and platelet P-selectin responses to acute psychological stress among elderly caregiversCardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.Von Willebrand Factor Plasma Levels Variability In Nonvalvular Atrial Fibrillation.Clopidogrel hydrogen sulphate for atrial fibrillation.Biomarkers in atrial fibrillation: an overview.Inflammation and the pathogenesis of atrial fibrillation.Platelets Cellular and Functional Characteristics in Patients with Atrial Fibrillation: A Comprehensive Meta-Analysis and Systematic Review.Predictive Role of Coagulation, Fibrinolytic, and Endothelial Markers in Patients with Atrial Fibrillation, Stroke, and Thromboembolism: A Meta-Analysis, Meta-Regression, and Systematic Review.Ex vivo thrombin generation in patients with venous thromboembolic disease or atrial fibrillation on long-term oral anticoagulation.Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences.Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation.Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy?Pharmacologic strategies for the prevention of stroke in patients with atrial fibrillation.Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation.
P2860
Q33725910-81E7F64A-A0E5-470E-8BE2-A86EFBDCA549Q34512403-053EB2D3-8878-491B-9B11-2AEF4E41F1D2Q34585334-8F3C4125-38E0-4ADB-8F7F-C5573767F082Q35605552-F2CA343C-40C3-4CFF-8B90-A8670CCB3F66Q36087921-901B64B5-61A7-486F-AD34-728982E036B5Q36741141-62B12256-EB6A-41D5-B48A-78CC772BB01AQ37464600-FC36A878-7900-4BE4-8738-95BF2ECE749AQ37468947-CE18D3EF-CE00-45CB-B40C-ED90068381D9Q37887815-C1D51BE7-415B-41DF-B97A-D4A5C6F1C295Q38174213-11B747ED-E923-4680-8AB1-A0CF5E660589Q38333088-1CE15287-3EED-454F-BF52-FCCDA38BADC8Q39182923-3BECA22E-1569-4F59-8F3C-C7A55968B72DQ39209674-48BBD037-040F-40AD-AC29-D8DFDC4D0420Q42163618-66189CDD-EDEF-4DD0-9980-FF8279A3C959Q44055036-BB97740D-77D6-4A58-9501-033E0B634B11Q48135990-8CF7FB01-9114-4BAB-8956-202BF5846E30Q49349357-3AC84832-CB76-484C-BCD2-312742DA373BQ53150344-0BE4130B-1BB3-47C6-91E0-B0AD152054F4Q55059334-C4ADA889-9214-4C21-90BD-F6A4A10B428A
P2860
A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
A longitudinal population-base ...... the Rotterdam Study 1990-1999.
@en
A longitudinal population-base ...... the Rotterdam Study 1990-1999.
@nl
type
label
A longitudinal population-base ...... the Rotterdam Study 1990-1999.
@en
A longitudinal population-base ...... the Rotterdam Study 1990-1999.
@nl
prefLabel
A longitudinal population-base ...... the Rotterdam Study 1990-1999.
@en
A longitudinal population-base ...... the Rotterdam Study 1990-1999.
@nl
P2093
P2860
P1476
A longitudinal population-base ...... the Rotterdam Study 1990-1999.
@en
P2093
Breteler MM
Heeringa J
Witteman JC
van der Kuip DA
P2860
P304
P356
10.1111/J.1538-7836.2006.02115.X
P577
2006-07-05T00:00:00Z